FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sara Fuchs

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Co-author Network

Publications

TOP 3
Revital Aricha; Sonia Berrih-Aknin; Tali Feferman; Sara Fuchs; Miriam C Souroujon
Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.
Miriam C Souroujon; Revital Aricha; Tali Feferman; Keren Mizrachi; Debby Reuveni; Sara Fuchs
Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Revital Aricha; Keren Mizrachi; Sara Fuchs; Miriam C Souroujon
Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sara Fuchs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Revital Aricha; Sonia Berrih-Aknin; Tali Feferman; Sara Fuchs; Miriam C Souroujon
Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.
Annals of the New York Academy of Sciences 2012;1275():107-13.
2012: Miriam C Souroujon; Revital Aricha; Tali Feferman; Keren Mizrachi; Debby Reuveni; Sara Fuchs
Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Annals of the New York Academy of Sciences 2012;1274():120-6.
2011: Revital Aricha; Keren Mizrachi; Sara Fuchs; Miriam C Souroujon
Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
Journal of autoimmunity 2011;36(2):135-41.
2011: Revital Aricha; Tali Feferman; Hamish S Scott; Miriam C Souroujon; Sonia Berrih-Aknin; Sara Fuchs
The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.
Journal of autoimmunity 2011;36(1):16-24.
2010: Keren Mizrachi; Revital Aricha; Tali Feferman; Neta Kela-Madar; Ilana Mandel; Tamar Paperna; Ariel Miller; Avraham Ben-Nun; Sonia Berrih-Aknin; Miriam C Souroujon; Sara Fuchs
Involvement of phosphodiesterases in autoimmune diseases.
Journal of neuroimmunology 2010;220(1-2):43-51.
2009: Tali Feferman; Revital Aricha; Keren Mizrachi; Erez Geron; Ronen Alon; Miriam C Souroujon; Sara Fuchs
Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.
Journal of neuroimmunology 2009;209(1-2):87-95.
2008: Renuka T R Menon; Tali Feferman; Revital Aricha; Miriam C Souroujon; Sara Fuchs
Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.
Journal of neuroimmunology 2008;201-202():128-35.
2008: Revital Aricha; Tali Feferman; Sara Fuchs; Miriam C Souroujon
Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(4):2132-9.
2008: Sara Fuchs; Tali Feferman; Roberto Meidler; Raanan Margalit; Camille Sicsic; Ningshan Wang; Kai-Yun Zhu; Talma Brenner; Orgad Laub; Miriam C Souroujon
A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
Journal of neuroimmunology 2008;194(1-2):89-96.
2008: Sara Fuchs; Tali Feferman; Roberto Meidler; Raanan Margalit; Camille Sicsic; Talma Brenner; Orgad Laub; Miriam C Souroujon
Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.
Annals of the New York Academy of Sciences 2008;1132():244-8.
2008: Sara Fuchs; Tali Feferman; Roberto Meidler; Talma Brenner; Orgad Laub; Miriam C Souroujon
The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model.
The Israel Medical Association journal : IMAJ 2008;10(1):58-60.
2007: Sara Fuchs; Tali Feferman; Kai-Yun Zhu; Roberto Meidler; Raanan Margalit; Ningshan Wang; Orgad Laub; Miriam C Souroujon
Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.
Annals of the New York Academy of Sciences 2007;1110():550-8.
2007: Tali Feferman; Revital Aricha; Renuka Menon; Miriam C Souroujon; Sonia Berrih-Aknin; Sara Fuchs
DNA microarray in search of new drug targets for myasthenia gravis.
Annals of the New York Academy of Sciences 2007;1107():111-7.
2006: Kai-Yun Zhu; Tali Feferman; Prasanta Maiti; Miriam C Souroujon; Sara Fuchs
Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms.
Journal of neuroimmunology 2006;176(1-2):187-97.
2006: Revital Aricha; Tali Feferman; Miriam C Souroujon; Sara Fuchs
Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(2):374-6.
2006: Orly Perl; Rael D Strous; Angela Dranikov; Rina Chen; Sara Fuchs
Low levels of alpha7-nicotinic acetylcholine receptor mRNA on peripheral blood lymphocytes in schizophrenia and its association with illness severity.
Neuropsychobiology 2006;53(2):88-93.
2005: Tali Feferman; Prasanta Maiti; Sonia Berrih-Aknin; Jacky Bismuth; Jocelyne Bidault; Sara Fuchs; Miriam C Souroujon
Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(9):5324-31.
2004: Tal Ilani; Rael D Strous; Sara Fuchs
Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(13):1600-2.
2004: Prasanta Maiti; Tali Feferman; Sin-Hyeog Im; Miriam C Souroujon; Sara Fuchs
Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment.
Journal of neuroimmunology 2004;152(1-2):112-20.
2003: Orly Perl; Tal Ilani; Rael D Strous; Raya Lapidus; Sara Fuchs
The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(13):1948-50.
2003: Miriam C Souroujon; Prasanta Maiti; Tali Feferman; Sin-Hyeog Im; Lily Raveh; Sara Fuchs
Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors.
Annals of the New York Academy of Sciences 2003;998():533-6.
2003: Tali Feferman; Sin-Hyeog Im; Sara Fuchs; Miriam C Souroujon
Epitope spreading to hidden cytoplasmic regions of the acetylcholine receptor in experimental autoimmune myasthenia gravis.
Annals of the New York Academy of Sciences 2003;998():388-90.
2003: Sara Fuchs; Roni Kasher; Moshe Balass; Tali Scherf; Michal Harel; Mati Fridkin; Joel Sussman; Ephraim Katchalski-Katzir
The binding site of acetylcholine receptor: from synthetic peptides to solution and crystal structure.
Annals of the New York Academy of Sciences 2003;998():93-100.
2003: Tali Feferman; Sin-Hyeog Im; Sara Fuchs; Miriam C Souroujon
Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis.
Journal of neuroimmunology 2003;140(1-2):153-8.
2003: Prasanta Maiti; Sin-Hyeog Im; Miriam C Souroujon; Sara Fuchs
A monoclonal antibody specific for rat IL-18BP and its application in determining serum IL-18BP.
Immunology letters 2003;85(1):65-70.
2003: Ephraim Katchalski-Katzir; Roni Kasher; Moshe Balass; Tali Scherf; Michal Harel; Mati Fridkin; Joel Sussman; Sara Fuchs
Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity and mimic the three-dimensional structure of the binding-site of acetylcholine receptor.
Biophysical chemistry 2003;100(1-3):293-305.
2002: Sin-Hyeog Im; Dora Barchan; Tali Feferman; Lily Raveh; Miriam C Souroujon; Sara Fuchs
Protective molecular mimicry in experimental myasthenia gravis.
Journal of neuroimmunology 2002;126(1-2):99-106.
2002: Sin-Hyeog Im; Soo-Hyun Kim; Tania Azam; Natarajan Venkatesh; Charles A Dinarello; Sara Fuchs; Miriam C Souroujon
Rat interleukin-18 binding protein: cloning, expression, and characterization.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(3):321-8.
2002: Tal Ilani; C Simone Fishburn; Berta Levavi-Sivan; Shari Carmon; Lily Raveh; Sara Fuchs
Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptors.
Cellular and molecular neurobiology 2002;22(1):47-56.
2001: Michal Harel; Roni Kasher; A Nicolas; J M Guss; Moshe Balass; Mati Fridkin; August B Smit; Katjusa Brejc; Titia K Sixma; Ephraim Katchalski-Katzir; Joel Sussman; Sara Fuchs
The binding site of acetylcholine receptor as visualized in the X-Ray structure of a complex between alpha-bungarotoxin and a mimotope peptide.
Neuron 2001;32(2):265-75.
2001: Sin-Hyeog Im; Dora Barchan; Prasanta Maiti; Lily Raveh; Miriam C Souroujon; Sara Fuchs
Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(12):2140-8.
2001: Moshe Balass; Edna Kalef; Sara Fuchs; Ephraim Katchalski-Katzir
A cyclic peptide with high affinity to alpha-bungarotoxin protects mice from the lethal effect of the toxin.
Toxicon : official journal of the International Society on Toxinology 2001;39(7):1045-51.
2001: Tali Scherf; Roni Kasher; Moshe Balass; Mati Fridkin; Sara Fuchs; Ephraim Katchalski-Katzir
A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicity.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(12):6629-34.
2001: Sin-Hyeog Im; Dora Barchan; Prasanta Maiti; Sara Fuchs; Miriam C Souroujon
Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(11):6893-8.
2001: Roni Kasher; Moshe Balass; Tali Scherf; Mati Fridkin; Sara Fuchs; Ephraim Katchalski-Katzir
Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity.
Chemistry & biology 2001;8(2):147-55.
2001: Tal Ilani; Dorit Ben-Shachar; Rael D Strous; M Mazor; A Sheinkman; M Kotler; Sara Fuchs
A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(2):625-8.
2000: Sin-Hyeog Im; Dora Barchan; Sara Fuchs; Miriam C Souroujon
Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis.
Journal of neuroimmunology 2000;111(1-2):161-8.
2000: Sin-Hyeog Im; Dora Barchan; Miriam C Souroujon; Sara Fuchs
Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(7):3599-605.
2000: Natarajan Venkatesh; Sin-Hyeog Im; Moshe Balass; Sara Fuchs; Ephraim Katchalski-Katzir
Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(2):761-6.
1999: Sin-Hyeog Im; Dora Barchan; Sara Fuchs; Miriam C Souroujon
Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.
The Journal of clinical investigation 1999;104(12):1723-30.
1999: J Obadiah; Tomer Avidor-Reiss; C Simone Fishburn; Shari Carmon; Michael Bayewitch; zvi vogel; Sara Fuchs; Berta Levavi-Sivan
Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs.
Cellular and molecular neurobiology 1999;19(5):653-64.
1999: Dora Barchan; Miriam C Souroujon; Sin-Hyeog Im; C Antozzi; Sara Fuchs
Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(14):8086-91.
1998: Berta Levavi-Sivan; B H Park; Sara Fuchs; C Simone Fishburn
Human D3 dopamine receptor in the medulloblastoma TE671 cell line: cross-talk between D1 and D3 receptors.
FEBS letters 1998;439(1-2):138-42.
1998: O Asher; Monica Lupu-Meiri; BS Jensen; T Paperna; Sara Fuchs; Yoram Oron
Functional characterization of mongoose nicotinic acetylcholine receptor alpha-subunit: resistance to alpha-bungarotoxin and high sensitivity to acetylcholine.
FEBS letters 1998;431(3):411-4.
1998: Miriam C Souroujon; Dora Barchan; Sara Fuchs
Modulation of experimental autoimmune myasthenia gravis by recombinant fragments of the human acetylcholine receptor.
Annals of the New York Academy of Sciences 1998;841():572-5.
1998: O Asher; Monica Lupu-Meiri; BS Jensen; T Paperna; Yoram Oron; Sara Fuchs
How does the mongoose cope with alpha-bungarotoxin? Analysis of the mongoose muscle AChR alpha-subunit.
Annals of the New York Academy of Sciences 1998;841():97-100.
1998: S Ariel; O Asher; Dora Barchan; M Ovadia; Sara Fuchs
The mongoose neuronal acetylcholine receptor (alpha 7) binds alpha-bungarotoxin.
Annals of the New York Academy of Sciences 1998;841():93-6.
1998: O Asher; BS Jensen; Monica Lupu-Meiri; Yoram Oron; Sara Fuchs
The mongoose acetylcholine receptor alpha-subunit: analysis of glycosylation and alpha-bungarotoxin binding.
FEBS letters 1998;426(2):212-6.
1998: Dora Barchan; O Asher; Socrates J Tzartos; Sara Fuchs; Miriam C Souroujon
Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
European journal of immunology 1998;28(2):616-24.
1997: B Skaaning Jensen; Berta Levavi-Sivan; C Simone Fishburn; Sara Fuchs
Functional expression of the murine D2, D3, and D4 dopamine receptors in Xenopus laevis oocytes.
FEBS letters 1997;420(2-3):191-5.
1997: Tali Scherf; Moshe Balass; Sara Fuchs; Ephraim Katchalski-Katzir; Jacob Anglister
Three-dimensional solution structure of the complex of alpha-bungarotoxin with a library-derived peptide.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6059-64.
1997: Moshe Balass; Ephraim Katchalski-Katzir; Sara Fuchs
The alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor: analysis using a phage-epitope library.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6054-8.
1996: Moshe Balass; Ely Morag; Edward A Bayer; Sara Fuchs; Meir Wilchek; Ephraim Katchalski-Katzir
Recovery of high-affinity phage from a nitrostreptavidin matrix in phage-display technology.
Analytical biochemistry 1996;243(2):264-9.
1996: D Accili; C Simone Fishburn; John Drago; H Steiner; J E Lachowicz; B H Park; Estelle B Gauda; E J Lee; M H Cool; David R Sibley; Charles R Gerfen; Heiner Westphal; Sara Fuchs
A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(5):1945-9.
1996: C Simone Fishburn; M Bedford; Peter Lonai; Sara Fuchs
Early expression of D3 dopamine receptors in murine embryonic development.
FEBS letters 1996;381(3):257-61.
1995: C Simone Fishburn; Zvulun Elazar; Sara Fuchs
Differential glycosylation and intracellular trafficking for the long and short isoforms of the D2 dopamine receptor.
The Journal of biological chemistry 1995;270(50):29819-24.
1995: Sylvia Kachalsky; B S Jensen; Dora Barchan; Sara Fuchs
Two subsites in the binding domain of the acetylcholine receptor: an aromatic subsite and a proline subsite.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(23):10801-5.
1995: Dora Barchan; Moshe Balass; Miriam C Souroujon; Ephraim Katchalski-Katzir; Sara Fuchs
Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(9):4264-9.
1995: Dora Barchan; M Ovadia; E Kochva; Sara Fuchs
The binding site of the nicotinic acetylcholine receptor in animal species resistant to alpha-bungarotoxin.
Biochemistry 1995;34(28):9172-6.
1995: M J Kornstein; O Asher; Sara Fuchs
Acetylcholine receptor alpha-subunit and myogenin mRNAs in thymus and thymomas.
The American journal of pathology 1995;146(6):1320-4.
1995: C Simone Fishburn; S Carmon; Sara Fuchs
Molecular cloning and characterisation of the gene encoding the murine D4 dopamine receptor.
FEBS letters 1995;361(2-3):215-9.
1995: B H Park; C Simone Fishburn; S Carmon; D Accili; Sara Fuchs
Structural organization of the murine D3 dopamine receptor gene.
Journal of neurochemistry 1995;64(2):482-6.
1994: C Simone Fishburn; C David; S Carmon; C Wein; Sara Fuchs
In vitro translation of D2 dopamine receptors and their chimaeras: analysis by subtype-specific antibodies.
Biochemical and biophysical research communications 1994;205(2):1460-6.
1994: O Asher; Sara Fuchs; Miriam C Souroujon
Acetylcholine receptor and myogenic factor gene expression in Torpedo embryonic development.
Neuroreport 1994;5(13):1581-4.
1994: C Simone Fishburn; C David; S Carmon; Sara Fuchs
The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain.
FEBS letters 1994;339(1-2):63-6.
1993: O Asher; Wilfried Kues; Veit Witzemann; S J Tzartos; Sara Fuchs; Miriam C Souroujon
Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(11):6442-50.
1993: Moshe Balass; Y Heldman; S Cabilly; David Givol; Ephraim Katchalski-Katzir; Sara Fuchs
Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(22):10638-42.
1993: C David; C Simone Fishburn; F J Monsma; David R Sibley; Sara Fuchs
Synthesis and processing of D2 dopamine receptors.
Biochemistry 1993;32(32):8179-83.
1993: Miriam C Souroujon; S Carmon; Sara Fuchs
Regulation of experimental autoimmune myasthenia gravis by synthetic peptides of the acetylcholine receptor.
Annals of the New York Academy of Sciences 1993;681():332-4.
1993: Sara Fuchs; Dora Barchan; Sylvia Kachalsky; D Neumann; M Aladjem; zvi vogel; M Ovadia; E Kochva
Molecular evolution of the binding site of the acetylcholine receptor.
Annals of the New York Academy of Sciences 1993;681():126-39.
1993: C Simone Fishburn; D Belleli; C David; S Carmon; Sara Fuchs
A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop.
The Journal of biological chemistry 1993;268(8):5872-8.
1993: Sylvia Kachalsky; M Aladjem; Dora Barchan; Sara Fuchs
The ligand binding domain of the nicotinic acetylcholine receptor. Immunological analysis.
FEBS letters 1993;318(3):264-8.
1992: Miriam C Souroujon; S Carmon; Sara Fuchs
Modulation of anti-acetylcholine receptor antibody specificities and of experimental autoimmune myasthenia gravis by synthetic peptides.
Immunology letters 1992;34(1):19-25.
1992: Dora Barchan; Sylvia Kachalsky; D Neumann; zvi vogel; M Ovadia; E Kochva; Sara Fuchs
How the mongoose can fight the snake: the binding site of the mongoose acetylcholine receptor.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(16):7717-21.
1992: O Asher; Sara Fuchs; D Zuk; D Rapaport; A Buonanno
Changes in the expression of mRNAs for myogenic factors and other muscle-specific proteins in experimental autoimmune myasthenia gravis.
FEBS letters 1992;299(1):15-8.
1991: C David; Sara Fuchs
Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
Molecular pharmacology 1991;40(5):712-6.
1991: C David; M Ewert; P H Seeburg; Sara Fuchs
Antipeptide antibodies differentiate between long and short isoforms of the D2 dopamine receptor.
Biochemical and biophysical research communications 1991;179(2):824-9.
1991: Miriam C Souroujon; S Carmon; A Safran; Sara Fuchs
Differences between embryonic and adult Torpedo acetylcholine receptor gamma subunit.
FEBS letters 1991;288(1-2):222-6.
1991: O Asher; C Provenzano; Sara Fuchs
Regulation of acetylcholine receptor gene expression in rats treated with alpha-bungarotoxin.
FEBS letters 1991;282(2):242-6.
1991: Zvulun Elazar; Sara Fuchs
Phosphorylation by cyclic AMP-dependent protein kinase modulates agonist binding to the D2 dopamine receptor.
Journal of neurochemistry 1991;56(1):75-80.
1991: Zvulun Elazar; Sara Fuchs
Vanadate inhibits agonist binding to D2 dopamine receptor.
Journal of molecular neuroscience : MN 1991;3(1):1-6.
1990: A Safran; C Provenzano; R Sagi-Eisenberg; Sara Fuchs
Phosphorylation of membrane-bound acetylcholine receptor by protein kinase C: characterization and subunit specificity.
Biochemistry 1990;29(28):6730-4.
1990: O Asher; D Neumann; Veit Witzemann; Sara Fuchs
Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis.
FEBS letters 1990;267(2):231-5.
1990: J Grodzicki; M Pardo; G Schved; A Schlosberg; Sara Fuchs; Hannah Kanety
Differences in [3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and nonresponsive schizophrenic patients.
Biological psychiatry 1990;27(12):1327-30.
1990: S Brocke; Molly Dayan; J Rothbard; Sara Fuchs; Edna Mozes
The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit.
Immunology 1990;69(4):495-500.
1989: Sara Fuchs; O Asher; D Neumann
Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis: correlation with disease.
Israel journal of medical sciences 1989;25(12):690-2.
1989: D Neumann; Dora Barchan; M Horowitz; E Kochva; Sara Fuchs
Snake acetylcholine receptor: cloning of the domain containing the four extracellular cysteines of the alpha subunit.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(18):7255-9.
1989: Zvulun Elazar; G Siegel; Sara Fuchs
Association of two pertussis toxin-sensitive G-proteins with the D2-dopamine receptor from bovine striatum.
The EMBO journal 1989;8(8):2353-7.
1988: S Brocke; Chaim Brautbar; Lawrence Steinman; Oded Abramsky; J Rothbard; D Neumann; Sara Fuchs; Edna Mozes
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
The Journal of clinical investigation 1988;82(6):1894-900.
1988: Zvulun Elazar; Hannah Kanety; C David; Sara Fuchs
Purification of the D-2 dopamine receptor from bovine striatum.
Biochemical and biophysical research communications 1988;156(1):602-9.
1988: Hannah Kanety; Sara Fuchs
Immuno-photoaffinity labeling of the D2-dopamine receptor.
Biochemical and biophysical research communications 1988;155(2):930-6.
1988: O Asher; D Neumann; Sara Fuchs
Increased levels of acetylcholine receptor alpha-subunit mRNA in experimental autoimmune myasthenia gravis.
FEBS letters 1988;233(2):277-81.
1988: Hannah Kanety; M Schreiber; Zvulun Elazar; Sara Fuchs
Antibodies against haloperidol specific to the butyrophenone moiety.
Journal of neuroimmunology 1988;18(1):25-36.
1988: Zvulun Elazar; Hannah Kanety; M Schreiber; Sara Fuchs
Anti-idiotypes against a monoclonal anti-haloperidol antibody bind to dopamine receptor.
Life sciences 1988;42(20):1987-93.
1987: A Safran; R Sagi-Eisenberg; D Neumann; Sara Fuchs
Phosphorylation of the acetylcholine receptor by protein kinase C and identification of the phosphorylation site within the receptor delta subunit.
The Journal of biological chemistry 1987;262(22):10506-10.
1987: Sara Fuchs; D Neumann; A Safran; S Pizzighella; R Mantegazza; Mathew P Daniels; zvi vogel
Species specificity of anti-acetylcholine receptor antibodies elicited by synthetic peptides.
Biochemistry 1987;26(15):4611-6.
1987: Miriam C Souroujon; Sara Fuchs
Antiidiotypic antibodies in the regulation of experimental autoimmune myasthenia gravis.
Annals of the New York Academy of Sciences 1987;505():676-82.
1987: Sara Fuchs; D Neumann; A Safran; Miriam C Souroujon; Dora Barchan; Mati Fridkin; J M Gershoni; R Mantegazza; S Pizzighella
Synthetic peptides and their antibodies in the analysis of the acetylcholine receptor.
Annals of the New York Academy of Sciences 1987;505():256-71.
1986: D Neumann; Dora Barchan; Mati Fridkin; Sara Fuchs
Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(23):9250-3.
1986: D Neumann; Dora Barchan; A Safran; J M Gershoni; Sara Fuchs
Mapping of the alpha-bungarotoxin binding site within the alpha subunit of the acetylcholine receptor.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(9):3008-11.
1986: Miriam C Souroujon; D Neumann; S Pizzighella; Mati Fridkin; Sara Fuchs
Mapping of the cAMP-dependent phosphorylation sites on the acetylcholine receptor.
The EMBO journal 1986;5(3):543-6.
1986: Miriam C Souroujon; D Neumann; S Pizzighella; A Safran; Sara Fuchs
Localization of a highly immunogenic region on the acetylcholine receptor alpha-subunit.
Biochemical and biophysical research communications 1986;135(1):82-9.
1985: Miriam C Souroujon; S Pizzighella; Daria Mochly-Rosen; Sara Fuchs
Antigenic specificity of acetylcholine receptor in developing muscle. Studies with monoclonal antibodies.
Journal of neuroimmunology 1985;8(2-3):159-66.
1985: Miriam C Souroujon; Dora Barchan; Sara Fuchs
Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes.
Immunology letters 1985;9(6):331-6.
1983: S Pizzighella; A S Gordon; Miriam C Souroujon; Daria Mochly-Rosen; A Sharp; Sara Fuchs
An anti-acetylcholine receptor monoclonal antibody cross-reacts with phosvitin.
FEBS letters 1983;159(1-2):246-50.